BioSpace News Archive

Heritage Health Solutions, the nation’s leading comprehensive integrated health care management solution, has announced a partnership with Meadows Behavioral Healthcare, more commonly known as The Meadows, to provide their virtual program, Heritage CARES, for active military, veterans and their families’ after-care treatment.

Inteleos™, a non-profit healthcare certification organization, announced today that it has named Ian Necus to its Board of Directors

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO).

PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirements

OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2021 financial results on Wednesday, May 5, 2021, after the market closes. OrthoPediatrics will host a conference call on Thursday, May 6, 2021, at 8:00 a.m. ET to discuss the results.

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that our Phase 1b study of ALX148 in patients with advanced gastric or gastroesophageal junction cancer has been selected for a short oral presentation at the ESMO 23 rd World Congress on Gastrointestinal Cancer to be held virtually from June 30 – July 3, 2021.

Evolus, Inc. announced that it has commenced a proposed underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced presentations featuring TransCon hGH (lonapegsomatropin) at two upcoming medical conferences: Pediatric Endocrinology Nursing Society (PENS) national conference, taking place virtually April 21-23,

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the first quarter 2021, after the market close on Wednesday, April 28, 2021.

BiaXam provides long-lasting protection in anti-microbial applications and kills up to 99.999% of SARS-CoV2.